Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsYves Pommier, Yongwei Zhang, Arun K. Ghosh
Life of this patent
Estimating the term…
Abstract
The present invention is directed towards lasonolide derivatives, methods of inducing premature chromosome condensation using lasonolide derivatives, and methods of treating disorders, such as cancer, in a subject, the method comprising administering to the subject a lasonolide derivative.
Claims8
A method of stimulating chromosome condensation in a cell, and observing chromosome condensation in the cell, wherein chromosome condensation is observed by a chromosome spread assay, a DNase I sensitivity assay, a phosphatase activity assay, an immunofluorescence assay, a cell adhesion assay, or a transwell migration assay;
- and the compound is chosen from
A method of analyzing human cell chromosomes by causing premature chromosome condensation, which comprises:
- (a) incubating a cell in vitro with a medium comprising a lasonolide derivative chosen from
- wherein the lasonolide derivative is present in an amount effective to induce premature chromosome condensation
- (b) analyzing the chromosomes treated in step a);
- wherein analyzing the chromosome comprises preparing a chromosome spread of the treated chromosomes;
- or
- hybridizing a detectable oligonucleotide to at least one or more chromosomes and enumerating chromosome spots.
A culture medium for inducing premature chromosome condensation in a cell comprising a lasonolide derivative having mitosis enhancing properties present in an amount effective to induce premature chromosome condensation;
- wherein the lasonolide derivative is a selected from
- further comprising a phosphatase inhibitor selected from a group consisting of okadaic acid, salts of okadaic acid, calyculin A, cantharidic acid, cantharidin, cypermethrin, deltamethrin, dephostatin, 3,4-dephostatin, endothall, fenvalerate, fostriecin, microcystin-LA, microcystin-LF, microcystin-LR, microcystin-LW, microcyctin-RR, and microcystin-YR.
Dependencies are inferred from the claim text.